Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 307-276-4 | CAS number: 97592-79-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996-12-31 to 1997-01-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 2-Propanol, 1,1'-[[3-[(3-aminopropyl)amino]propyl]imino]bis-, N-tallow alkyl derivs.
- EC Number:
- 307-276-4
- EC Name:
- 2-Propanol, 1,1'-[[3-[(3-aminopropyl)amino]propyl]imino]bis-, N-tallow alkyl derivs.
- Cas Number:
- 97592-79-5
- Molecular formula:
- No molecular formula
- IUPAC Name:
- 2-Propanol, 1,1'-[[3-[(3-aminopropyl)amino]propyl]imino]bis-, N-tallow alkyl derivs.
- Details on test material:
- - Name of test material (as cited in study report): POLYRAM SL
- Physical state: yellow viscous liquid
- Analytical purity: 100 % (expressed in complex substance)
- Certificate of analysis date: 1996/03/04
- Lot/batch No.: 5788
- Expiration date of the lot/batch: 1997/03
- Storage condition of test material: in dark and at room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: IFFA- CREDO (69210 L'ARBRESLE, FRANCE)
- Age at study initiation: about 6 weeks
- Weight at study initiation: between 184g and 212g (males) and 170g and 183g (females)
- Fasting period before study: overnight prior to administration of the test substance
- Housing: 5 animals by sex in polypropylene cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): not reported
- Humidity (%): not reported
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): not reported
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: the test substance was prepared in Carboxymethyl cellulose (0.5%) at concentrations of 100 and 400 mg/mL for the 500 and the 2000 mg/kg bw dose groups respectively.
- Amount of vehicle (if gavage): 5 mL/kg bw for the 500 and the 2000 mg/kg bw dose groups
- Justification for choice of vehicle: solubility
- Lot/batch no. (if required): Cooper Batch B09710
- Purity:
MAXIMUM DOSE VOLUME APPLIED: 5 mL/kg bw - Doses:
- 2 groups of 10 animals (5 of each sex)
Doses : Group 1 : 500mg/kg
Group 2 : 2000mg/kg
These doses were chosen according to a preliminary "sighting" study performed on a few number of animals. - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - The animals were observed daily for 14 days after treatment.
- Mortalities were checked twice a day during all the observation period.
- A clinical examination was carried out one hour after treatment and frequently during the five hours following treatment and then at least once a day for 14 days.
- Body weights of the animals were recorded just prior to treatment (D1) and then on days 3, 7 and 14 after treatment.
- The animals found dead during the test were immediately necropsied.
- At the end of the 14 observation days, surviving animals were sacrified after barbituric anaesthia, then autopsied.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 500 - < 2 000 mg/kg bw
- Mortality:
- A mortality rate of 70% was induced with the dose of 2000mg/kg. The time of death chiefly occured between 6 hours and 72 hours following treatment. There were no death amongst animals treated at the dose of 500mg/kg (See table 1 in results and discussion free-text for details).
- Clinical signs:
- other: - At the 500 mg/kg bw dose-level, except a slight piloerection that appeared 30 minutes after the treatment and disappeared in less than 24 hours, no clinical signs were observed. - At the 2000 mg/kg bw dose-level, all the animals showed an important pilo
- Gross pathology:
- - Necropsy of animals found dead revealed some changes in lungs, liver, kidneys, spleen (congestion), stomach (distension) and intestine (distension).
- Necropsy of the male sacrified on D10 showed stomach adhesions with liver, spleen and abdominal wall and intestine distended with presence of liquid.
- Necropsy of the surviving animals, on day 15, revealed no significant macroscopic abnormality.
Any other information on results incl. tables
Table 1: Mortality at the 500 and 2000 mg/kg bw dose-levels
Dose | Male | Female | Total |
500 mg/kg | 0 | 0 | 0 |
2000 mg/kg | 2/5 (24 hours = Day 2)1/5 (Day 6)1/5 (Day 10) | 1/5 (24 hours = Day 2)2/5 (72 hours = Day 4) | 7/10 (end of study) |
Table 2: Bodyweight of male animals
dosed with 500 mg/kg bw
Animal# | 4481 | 4482 | 4483 | 4484 | 4485 | Mean | S.D. |
D1 | 206 | 184 | 195 | 198 | 197 | 196 | 7.9 |
D4 | 244 | 218 | 231 | 228 | 238 | 231.8 | 9.9 |
D8 | 293 | 259 | 273 | 266 | 277 | 273.6 | 12.8 |
D15 | 355 | 316 | 310 | 310 | 330 | 324.2 | 19.1 |
D15 -D1 | 149 | 132 | 115 | 112 | 133 | 128.2 | 15.1 |
Table 3: Bodyweight of female animals dosed with 500 mg/kg bw
Animal# | 4486 | 4487 | 4488 | 4489 | 4490 | Mean | S.D. |
D1 | 171 | 180 | 179 | 175 | 170 | 175 | 4.5 |
D4 | 191 | 202 | 199 | 185 | 199 | 195.5 | 7.0 |
D8 | 205 | 220 | 222 | 192 | 206 | 209 | 12.3 |
D15 | 202 | 229 | 223 | 210 | 220 | 216.8 | 10.8 |
D15 -D1 | 31 | 49 | 44 | 35 | 50 | 41.8 | 8.5 |
Table 4: Bodyweight of male animals dosed with 2000 mg/kg bw
Animal# | 4491 | 4492 | 4493 | 4494 | 4495 | Mean | S.D. |
D1 | 195 | 196 | 212 | 206 | 189 | 199.6 | 9.2 |
D4 | 162 | 159 | 186 | - | - | 169 | 14.8 |
D8 | 153 | - | 158 | - | - | 155.5 | 3.5 |
D15 | - | - | 250 | - | - | 250 | - |
D15 -D1 | - | - | 38 | - | - | 38 | - |
Table 5: Bodyweight of female animals dosed with 2000 mg/kg bw
Animal# | 4496 | 4497 | 4498 | 4499 | 4500 | Mean | S.D. |
D1 | 177 | 175 | 177 | 172 | 183 | 176.8 | 4.0 |
D4 | 170 | - | - | - | 168 | 169 | 1.4 |
D8 | 218 | - | - | - | 217 | 217.5 | 0.7 |
D15 | 233 | - | - | - | 240 | 236.5 | 4.9 |
D15 -D1 | 56 | - | - | - | 57 | 5605 | 0.7 |
Applicant's summary and conclusion
- Interpretation of results:
- other: Toxicity category 4 / Harmful
- Remarks:
- Criteria used for interpretation of results: other: CLP (Reg. 1272/2008/EC) and Directive 67/548/EEC
- Conclusions:
- Under these experimental conditions, the oral LD50 of the test item was comprised between 500 and 2000 mg/kg in rats.
- Executive summary:
The acute oral toxicity of the test item was evaluated in rats according to OECD guideline 401. The study was conducted in compliance with the principles of Good Laboratory Practice Regulations.
The test item was prepared in Carboxymethyl cellulose at 05% and was administered by oral route (gavage), under a volume of 5 mL/kg bw, to groups of five fasted male and female Sprague-Dawley rats. The dose-levels of 500 and 2000 mg/kg bw were selected on the basis of the results obtained in a preliminary sighting study.
In the main study, clinical signs, mortality and body weight gain were checked for a period of up to 14 days following the single administration of the test item. All animals were subjected to necropsy.
At the 500 mg/kg bw dose-level, no mortality occured. A slight piloerection that appeared 30 minutes after the treatment and disappeared in less than 24 hours was the only clinical sign. The body weight gain of the animals was not affected by treatment with the test item and no apparent abnormalities were observed in any animal at necropsy.
At the 2000 mg/kg bwdose-level, 70% (4/5 males and 3/5 females) of the animals died within the study period. Most of the deaths occured 24 to 72 hours after treatment . An important piloerection, a slight abdominal meteorism and a dirty urogenital area were noted in the surviving animals from day 2 to day 8. All animals lost weight at 72 hours but females (not males) recovered at day 8. Necropsy of animals found dead revealed changes in liver, spleen, kidney, lung, intestine and abdominal wall. Necropsies of animals surviving until end of study did not reveal any changes.
Under these experimental conditions, the oral LD50of the test item was comprised between 500 and 2000 mg/kg in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.